TrialBlood2008

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Stefan Faderl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.